EU medical devices unit completes move
This article was originally published in Clinica
The European Commission's medical devices unit, now in unit 3 of the European Commission's Directorate F on Consumer Goods within Directorate General Enterprise, has moved to the Breydel building in Brussels on June 10. The medical device staff are located on the tenth floor, with the rest of Directorate F, and now in close proximity to unit 2, the pharmaceuticals unit which is dealing with advanced therapies, including human tissue engineered products.
You may also be interested in...
Arcadia prohibited from arguing against Advantice’s appeal of National Advertising Division decision that Kerasal Fungal Nail Renewal ad claims weren’t supported. Arcadia violated confidentiality rule by publicizing NAD decision before the review was officially closed.
The C-suite leaders schemed to falsely record shipments of unwanted products to distributors as sales so the company could meet revenue projections, the government charged.
Gallium has been approved as a diagnostic agent by the US agency to help early detection of prostate cancer spread in patients who qualify for treatment with surgery or radiation therapy.